Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD 7009 is a novel antiarrhythmic compound that inhibits the sodium current of hNav1.5 in CHO K1 cells with an IC50 of 11 uM. AZD 7009 inhibited late sodium current in isolated rabbit atrial and ventricular myocytes, and prolonged E-4031-induced action potential duration, promoting early post-depolarization of Purkinye fibers (EADs).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 628.00 | |
5 mg | In stock | $ 1,350.00 | |
25 mg | In stock | $ 2,680.00 | |
50 mg | In stock | $ 3,630.00 |
Description | AZD 7009 is a novel antiarrhythmic compound that inhibits the sodium current of hNav1.5 in CHO K1 cells with an IC50 of 11 uM. AZD 7009 inhibited late sodium current in isolated rabbit atrial and ventricular myocytes, and prolonged E-4031-induced action potential duration, promoting early post-depolarization of Purkinye fibers (EADs). |
Synonyms | AZD-7009, AZD7009 |
Molecular Weight | 446.54 |
Formula | C23H34N4O5 |
CAS No. | 335619-18-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD 7009 335619-18-6 Membrane transporter/Ion channel Sodium Channel AZD-7009 AZD7009 inhibitor inhibit